Organogenesis Holdings Inc. provided earnings guidance for the year ending December 31, 2022. For the year ending December 31, 2022, the Company expects net revenue of between $448 million and $465 million, representing a decrease of approximately 1% to 4% year-over-year, and a decrease of 2% to an increase of 2% on an adjusted basis2, as compared to net revenue of $467.4 million3 for the year ended December 31, 2021. Net income in a range of approximately $12 million to $20 million.